Literature DB >> 23913339

Do monoblock cups improve survivorship, decrease wear, or reduce osteolysis in uncemented total hip arthroplasty?

Jelle J Halma1, H Charles Vogely, Wouter J Dhert, Steven M Van Gaalen, Arthur de Gast.   

Abstract

BACKGROUND: Monoblock acetabular components used in uncemented total hip arthroplasty (THA) have certain mechanical characteristics that potentially reduce acetabular osteolysis and polyethylene wear. However, the degree to which they achieve this goal is not well documented. QUESTIONS/PURPOSES: The purpose of this study was to use a systematic review of controlled trials to test the hypothesis that monoblock cups have superior (1) polyethylene wear rate; (2) frequency of cup migration; (3) frequency of acetabular osteolysis; and (4) frequency of aseptic loosening compared with modular components used in uncemented THA.
METHODS: A systematic search was conducted in the Medline, Embase, and Cochrane electronic databases to assemble all controlled trials comparing monoblock with modular uncemented acetabular components in primary THA. Included studies were considered "best evidence" if the quality score was either ≥ 50% on the Cochrane Back Review Group checklist or ≥ 75% the Newcastle-Ottawa quality assessment scale. A total of seven publications met our inclusion criteria.
RESULTS: Best evidence analysis showed no difference in polyethylene wear rate, the frequency of cup migration, and aseptic loosening between monoblock and modular acetabular components. No convincing evidence was found for the claim that lower frequencies of acetabular osteolysis are observed with the use of monoblock cups compared with modular uncemented cups.
CONCLUSIONS: The purported benefits of monoblock cups were not substantiated by this systematic review of controlled studies in that polyethylene wear rates and frequencies of cup failure and acetabular osteolysis were similar to those observed with modular implants. Other factors should therefore drive implant selection in cementless THA.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23913339      PMCID: PMC3792292          DOI: 10.1007/s11999-013-3144-y

Source DB:  PubMed          Journal:  Clin Orthop Relat Res        ISSN: 0009-921X            Impact factor:   4.176


  35 in total

1.  The Trabecular Metal Monoblock acetabular component in patients with high congenital hip dislocation: a prospective study.

Authors:  G A Macheras; K Kateros; S D Koutsostathis; G Tsakotos; S Galanakos; S A Papadakis
Journal:  J Bone Joint Surg Br       Date:  2010-05

2.  Bone remodeling around porous metal cementless acetabular components.

Authors:  R Michael Meneghini; Kerry S Ford; Cynthia H McCollough; Arlen D Hanssen; David G Lewallen
Journal:  J Arthroplasty       Date:  2009-05-26       Impact factor: 4.757

3.  Eight- to ten-year clinical and radiographic outcome of a porous tantalum monoblock acetabular component.

Authors:  George Macheras; Konstantinos Kateros; Athanassios Kostakos; Stefanos Koutsostathis; Dimitrios Danomaras; Panayiotis J Papagelopoulos
Journal:  J Arthroplasty       Date:  2008-08-13       Impact factor: 4.757

4.  The Morscher Press Fit acetabular component: a nine- to 13-year review.

Authors:  D P Gwynne-Jones; N Garneti; C Wainwright; J A Matheson; R King
Journal:  J Bone Joint Surg Br       Date:  2009-07

5.  2009 updated method guidelines for systematic reviews in the Cochrane Back Review Group.

Authors:  Andrea D Furlan; Victoria Pennick; Claire Bombardier; Maurits van Tulder
Journal:  Spine (Phila Pa 1976)       Date:  2009-08-15       Impact factor: 3.468

Review 6.  Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group.

Authors:  D F Stroup; J A Berlin; S C Morton; I Olkin; G D Williamson; D Rennie; D Moher; B J Becker; T A Sipe; S B Thacker
Journal:  JAMA       Date:  2000-04-19       Impact factor: 56.272

7.  Uncemented and cemented primary total hip arthroplasty in the Swedish Hip Arthroplasty Register.

Authors:  Nils P Hailer; Göran Garellick; Johan Kärrholm
Journal:  Acta Orthop       Date:  2010-02       Impact factor: 3.717

8.  The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration.

Authors:  Alessandro Liberati; Douglas G Altman; Jennifer Tetzlaff; Cynthia Mulrow; Peter C Gøtzsche; John P A Ioannidis; Mike Clarke; P J Devereaux; Jos Kleijnen; David Moher
Journal:  BMJ       Date:  2009-07-21

9.  Treatment for acetabular dysplasia using the uncemented RM acetabular component - a 20 year follow-up.

Authors:  Martin Ihle; Sabine Mai; Werner E Siebert
Journal:  Hip Int       Date:  2010 Jan-Mar       Impact factor: 1.756

10.  Comparison of trabecular metal cups and titanium fiber-mesh cups in primary hip arthroplasty: a randomized RSA and bone mineral densitometry study of 50 hips.

Authors:  Thomas Baad-Hansen; Søren Kold; Poul Torben Nielsen; Mogens Berg Laursen; Poul Hedevang Christensen; Kjeld Soballe
Journal:  Acta Orthop       Date:  2011-03-25       Impact factor: 3.717

View more
  3 in total

Review 1.  How have alternative bearings and modularity affected revision rates in total hip arthroplasty?

Authors:  William M Mihalko; Markus A Wimmer; Carol A Pacione; Michel P Laurent; Robert F Murphy; Carson Rider
Journal:  Clin Orthop Relat Res       Date:  2014-12       Impact factor: 4.176

2.  Backside Wear Analysis of Retrieved Acetabular Liners with a Press-Fit Locking Mechanism in Comparison to Wear Simulation In Vitro.

Authors:  Ana Laura Puente Reyna; Marcus Jäger; Thilo Floerkemeier; Sven Frecher; Karl-Stefan Delank; Christoph Schilling; Thomas M Grupp
Journal:  Biomed Res Int       Date:  2016-09-19       Impact factor: 3.411

3.  Raloxifene Prevents Early Periprosthetic Bone Loss for Postmenopausal Women after Uncemented Total Hip Arthroplasty: A Randomized Placebo-Controlled Clinical Trial.

Authors:  Long Gong; Yao-Yao Zhang; Na Yang; Huan-Juan Qian; Ling-Kun Zhang; Ming-Sheng Tan
Journal:  Orthop Surg       Date:  2020-07-19       Impact factor: 2.071

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.